# PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
> **NDA021703** · New Drug Application · Sponsor: VANTIVE US HLTHCARE · Approved 2006-10-25
## Drug
- **FDA Application Number:** NDA021703
- **Application type:** New Drug Application
- **Brand name:** PRISMASOL B22GK 2/0 IN PLASTIC CONTAINER
- **Generic name:** MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE
- **Active ingredients:** CALCIUM CHLORIDE; DEXTROSE; LACTIC ACID; MAGNESIUM CHLORIDE; POTASSIUM CHLORIDE; SODIUM BICARBONATE; SODIUM CHLORIDE
- **Dosage form:** INJECTABLE
- **Route:** INJECTION
- **Marketing status:** Discontinued
- **Sponsor:** VANTIVE US HLTHCARE
- **Manufacturer:** Vantive US Healthcare LLC
- **First approval:** 2006-10-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021703)
---
*AI Analytics · CC0 1.0*